EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pseudomonas aeruginosa Bacteriophages and Their Clinical Applications

Elaheh Alipour-Khezri iD, Mikael Skurnik iD, Gholamreza Zarrini iD

Viruses · 2024

DOI: 10.3390/v16071051 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, 2024. Verfasst von Elaheh Alipour-Khezri und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz 51368, Iran. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Pseudomonas Infections, Phage Therapy, Cystic Fibrosis. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 256 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial resistance poses a serious risk to contemporary healthcare since it reduces the number of bacterial illnesses that may be treated with antibiotics, particularly for patients with long-term conditions like cystic fibrosis (CF). People with a genetic predisposition to CF often have recurrent bacterial infections in their lungs due to a buildup of sticky mucus, necessitating long-term antibiotic treatment. Pseudomonas aeruginosa infections are a major cause of CF lung illness, and P. aeruginosa airway isolates are frequently resistant to many antibiotics. Bacteriophages (also known as phages), viruses that infect bacteria, are a viable substitute for antimicrobials to treat P. aeruginosa infections in individuals with CF. Here, we reviewed the utilization of P. aeruginosa bacteriophages both in vivo and in vitro, as well as in the treatment of illnesses and diseases, and the outcomes of the latter.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pseudomonas aeruginosaPseudomonas InfectionsPhage TherapyCystic FibrosisPseudomonas PhagesHumansAnimalsBacteriophagesAnti-Bacterial Agents

Stichwörter der Autor:innen

Pseudomonas aeruginosabacteriophagecystic fibrosisphage therapy

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz 51368, Iran.
  • Human Microbiome Research Program, and Department of Bacteriology and Immunology, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland.
  • Microbial Biotechnology Research Group, University of Tabriz, Tabriz 51368, Iran.

ORCID-Profile: Elaheh Alipour-Khezri, Mikael Skurnik, Gholamreza Zarrini

Zitieren

APA

Alipour-Khezri, E., Skurnik, M., & Zarrini, G. (2024). Pseudomonas aeruginosa Bacteriophages and Their Clinical Applications. Viruses. https://doi.org/10.3390/v16071051

Vancouver

Alipour-Khezri E, Skurnik M, Zarrini G. Pseudomonas aeruginosa Bacteriophages and Their Clinical Applications. Viruses. 2024. doi:10.3390/v16071051

BibTeX
@article{AlipourKhezri2024,
  author = {Alipour-Khezri, Elaheh and Skurnik, Mikael and Zarrini, Gholamreza},
  title = {Pseudomonas aeruginosa Bacteriophages and Their Clinical Applications},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16071051}
}
Kostenlos starten →